Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney
disease (DKD) remains one of the leading long-term complications of T2D. Several lines of …

Iron is an essential micronutrient for a myriad of physiological processes in the body beyond
erythropoiesis. Iron deficiency (ID) is a common comorbidity in patients with heart failure …

Aims To examine the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on
cardiac remodelling in patients with type 2 diabetes mellitus (T2DM) and/or heart failure …

Heart failure (HF) is a major health care burden increasing in prevalence over time.
Effective, evidence-based interventions for HF prevention and management are needed to …

The diagnosis of acute and chronic myocarditis remains a challenge for clinicians.
Characterization of this disease has been hampered by its diverse etiologies and …

After mass vaccination with messenger RNA (mRNA) vaccines against coronavirus disease
2019 (Covid-19), myocarditis in male teenagers emerged as a possible rare side effect …

The impressive results of recent clinical trials with glucagon-like peptide-1 receptor agonists
(GLP-1Ra) and sodium glucose transporter 2 inhibitors (SGLT-2i) in terms of cardiovascular …

Background Recent studies indicated that sodium glucose cotransporter (SGLT) 2 inhibition
increases levels of ketone bodies in the blood in patients with type 1 and 2 diabetes. Other …